Tracking Alzheimer’s disease progression at the earliest stages: a multimodal project
Project Overview
New neuroimaging techniques enable us to measure the key hallmarks of Alzheimer’s disease (AD) pathology before symptoms appear. The AD pathologic process is known to begin decades before the appearance of dementia symptoms such as memory or language deficits. Therefore, Dr. Villeneuve will use th…
See researchers on this project
Principal Investigator:
- Sylvia Villeneuve,
Douglas Hospital Research Centre
(McGill University)
Team Members:
- John Breitner, McGill University